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Introduction 
Extracorporeal shockwave lithrotripsy (ESWL) is an effective, non-invasive clinical 
therapy utilized to break up stones in the kidney and urinary tract. A lithotripter 
generates high-energy acoustic pulses and propagates those shock waves through a 
lens on a region that focuses on the location of the stone, in turn breaking up the 
stone. The successive pulses generate shearing forces and cavitation bubbles. 
Cavitation bubbles are the formation and implosion of liquid free zones. The 
cavitation bubbles implode rapidly to create their own shockwaves that also put 
pressure on the stone. After treatment, fragmentation of the stone allows the debris 
to be cleared by the flow of the urinary tract. The problem is that to break up the 
kidney stone, it requires many repetitive shock waves that not only hit the kidney 
stone but also the surrounding tissue. Although lithotripsy provides a safer 
alternative to invasive treatments for removing harmful stones, ESWL may cause 
prolonged vasoconstriction after ESWL treatment, reducing renal blood flow, and 
subsequent endothelial dysfunction, which may cause kidney damage leading to 
acute to chronic hypertension clinically. ESWL-induced vascular oxidative stress and 
further endothelial dysfunction may be mediated by reduced levels of endothelial-
derived nitric oxide (NO) and/or increased reactive oxygen species. Previous studies 
have shown that ESWL can induce oxidative stress, which can cause an increase in 
blood hydrogen peroxide (H2O2) and a decrease in endothelial-derived NO 
bioavailability release. Under normal conditions, tetrahydrobiopterin (BH4) is the 
cofactor to promote eNOS coupling, and endothelial-derived NO is produced. When 
the dihydrobiopterin (BH2) to tetrahydrobiopterin (BH4) ratio is increased during 
oxidative stress, such as ESWL, BH2 promotes eNOS uncoupling and produces 
superoxide (SO) instead of NO. (1,2) (Figure 1) SO is then later converted to H2O2 by 
superoxide dismutase.   BH4 and BH2 bind to eNOS with equal affinity, therefore the 
ratio will determine whether eNOS principally produces NO or SO. 
Methods 
Conclusions 
In ESWL-treated rats, blood NO release decreases and H2O2 increases post-ESWL 
compared to non-ESWL controls. This supports our hypothesis that ESWL treatment 
does induce oxidative stress and NO bioavailability is reduced, therefore ESWL does 
cause endothelial dysfunction in the kidney. In ESWL+BH4 treated rats, NO was 
significantly increased post-ESWL and H2O2 was significantly decreased compared to 
ESWL+Saline and ESWL+BH2 group. This supports our hypothesis that infusion of 
BH4 immediately post-ESWL will attenuate H2O2 release and increase NO 
bioavailability relative to ESWL+Saline. This may be due to BH4 promoting eNOS 
coupling to facilitate NO release. Our ESWL+BH2 group is similar to ESWL+Saline 
group. This may be due to BH2, promoting eNOS uncoupling, which leads to 
increased oxidative stress with decreased production of NO. Moreover, the 
ESWL+BH2  group was similar to ESWL+Saline controls regarding H2O2 release.  This 
may be due to eNOS  being saturated with BH2 under ESWL conditions. 
Results 
Male Sprague-Dawley rats (275-325 grams, Ace Animals, Boyertown, PA) were 
anesthetized using sodium pentobarbital with an induction dose of  60mg/kg via 
intraperitoneal injection. A maintenance dose (30mg/kg) was given at intervals of 
approximately 45 minutes. The rat was then injected via intraperitoenal injection with 
1mL sodium heparin (1000 USP units/mL) to prevent blood clotting. A 24-gauge 
catheter was inserted into the external jugular vein for drug or saline infusion 
immediately following ESWL treatment. A mid-line abdominal incision was performed 
and the left renal vein was exposed. Upon catheterization of the left renal vein with a 
22-gauge catheter, the NO or H2O2 microsensor (World Precision Instruments, Inc., 
Sarasota, FL) was inserted through the catheter and connected to the Apollo 4000 
Free Radical Analyzer. (World Precision Instruments, Inc.) The trace was recorded until 
a decrease of one picoamp per second, indicating a stable baseline. After 
establishment of a stable baseline, ESWL treatment was induced by a Dornier Epos 
Ultra HE (high-energy) lithotripter (Figure 2). ESWL treatment consisted of 
approximately 13 minutes of shockwaves, a total of 1000 shocks in two periods of 
16kV intensity were transmitted. The first 500 shocks were given at 60 beats per 
minute followed by 500 shocks at 120 beats per minute. Immediately post-ESWL 
treatment, 0.5 mL saline or drug bolus was infused through the jugular vein canulation 
followed by 0.5 mL of saline as a flush. Recordings were taken at the beginning and 
end of ESWL treatment, then in five minute intervals for 30 minutes post-ESWL 
treatment. 
 
A technique was developed to measure renal blood NO and H2O2 in real-time using 
microsensors. Molar concentration of free radicals could not be measured directly in 
vivo, therefore, microsensors, which receive an electrical signal proportional to the 
concentration of the free radical through a oxidation/reduction reaction, were used 
to measure NO and H2O2 levels. The free radical analyzer collected data in picoamps 
(pA). Each microsensor was calibrated before each experiment to calculate a 
standard calibration curve. The standard calibration curve was generated by a 
stepwise dose-response of the microsensor to the appropriate standard solution.  
 
Figure 3. Effect of BH4 and BH2 on Blood H2O2 levels after ESWL. H2O2 levels significantly 
decrease post-ESWL (5-30min) for ESWL+BH4 compared to ESWL+Saline. ESWL+BH2 was similar 
to ESWL_Saline. (*p≤0.05, **p≤0.01, compared to ESWL+Saline) (#p≤0.05, ##p≤0.01, compared 
to ESWL+BH2) 
Figure 4. Effect of BH4 and BH2 on Blood NO levels after ESWL. ESWL+ BH4 group is similar to 
non-ESWL control; significantly attenuates decreased NO levels (5-30 min post-ESWL) 
compared to ESWL+Saline groups. ESWL+ BH2 group is similar to ESWL+Saline group. 
(*p≤0.05, **p≤0.01, compared to ESWL+Saline) (#p≤0.05, ##p≤0.01, compared to ESWL+BH2) 
Figure 2. The rat is placed on a board that maintains the left kidney within the focal 
point of the shock wave transmitter on the lithotripter’s mechanical arm. The 
microsenor is inserted into the left renal vein and supported by gauze in direct 
opposition to the renal vein blood flow. 
The recorded electrical signal in pAs were converted to molar concentration using the 
standard curve from each calibration. For statistical analysis, all data were 
presented as means ±SEM.  The data for each time-point in the recordings were 
analyzed by ANOVA using Bonferroni-Dunn. Probability values of less than 0.05 were 
considered to be statistically significant. 
Experimental Groups: 
Nitric Oxide (NO) 
 Group 1: No-ESWL, Saline infusion 
(Control) (n=6) 
 Group 2: ESWL, Saline infusion (Control) 
(n=5) 
 Group 3: ESWL + BH4 6.5 mg/kg (250 
μM) (n=5) 
 Group 4: ESWL + BH2 2.0 mg/kg (100 
μM) (n=5) 
Hydrogen Peroxide (H2O2) 
 Group 5: No-ESWL, Saline infusion 
(Control) (n=5) 
 Group 6: ESWL, Saline infusion (Control) 
(n=5) 
 Group 7: ESWL + BH4  6.5 mg/kg (250 
μM) (n=5) 
 Group 8: ESWL + BH2 2.0 mg/kg (100μM) 
(n=5)  
 
Hypothesis 
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Figure 1. With BH4 cofactor, coupled eNOS produces NO. During oxidative stress, BH4 is 
oxidized to BH2 , and the BH2 to BH4 ratio is increased. With BH2 as the cofactor, eNOS 
becomes uncoupled. Unable to shuttle electrons to use L-Arginine as a substrate, 
uncoupled eNOS transfers the electrons to produce SO. Later, SO is converted to 
hydrogen peroxide  by SOD.  Adapted from Chen et al. 2010 (1.) 
We hypothesize that the introduction of ESWL will decrease NO release in left renal 
veins compared to controls receiving no ESWL.  Whereas, an increase in H2O2 release 
is expected in the ESWL + Saline group compared to the non-ESWL group.   When 
tetrahydrobiopterin (BH4)(mol. wt. 241.25)(Cayman Chemicals) is given at the end of 
ESWL treatment we predict a decrease in H2O2 release and an increase in NO release 
compared to ESWL + saline group. On the contrary, when dihydrobiopterin  
(BH2 )(mol. wt. 239.23)(Cayman Chemicals) is given at the end of ESWL treatment we 
predict an increase in H2O2 release and decrease in NO release compared to ESWL + 
Saline group. 
